Home >

Welcome to ASCO Connection Discussion

Filter by Practice
Mark R. Hutchins, MD
Apr 26, 2016 10:50 PM
Has there ever been a PRCT of AC/T vs "other" in a pure TNBC stratified group (in the NeoAdj setting or the Adj setting?) showing that AC/T vs "other" showed a superior survival? When we say that AC/T shows a survival advantage, advantage over what?
The origninal AC vs CMF showed little if any...
Arsh Singh, MD
Jan 18, 2016 1:00 PM
In a 33 y/o caucasian woman with T2N0 Her 2 Positive invasive ductal carcinoma (both by IHC and FISH), ER 50% and PR negative, is it okay to use AC followed by T along with herceptin and pertuzumab  in the neoadjuvant setting?
Joseph Kim, MD, MPH
Oct 09, 2015 8:57 AM
This article in JAMA titled, "Facilitating Quality Improvement - Pushing the Pendulum Back Toward Process Measures" caught my attention the other day. The author starts by reflecting on the ongoing debate: should we focus more...
Sruthi Mukku
Apr 15, 2015 11:19 AM
my question is if a patinet biopsy for wide execison tells that there is no metasasis ,no  neocrisis , mitotic is 4-6/10HPF no lymph node involvement and of free of all cancer then should the patient worry for the recoccurance in future
please reply , i had only guest login for today


Tweets from ASCO

Tweets from Oncology Community